Wayne chats with Jessica O'Connell, Partner at Covington and Co-Chair of the firm's Food, Drug, and Device Practice Group; and Rebecca Dandeker, Partner in the Food and Drug Practice at Wiley Rein. You'll hear their thoughts on the recent leadership changes at FDA; unanswered questions for the cosmetics industry as they move into long-term compliance with FDA's MoCRA requirements; the agency's draft guidance on its mandatory recall authority for cosmetics; how companies should be thinking risk management amid an influx of state regulatory movement; challenges balancing science, enforcement, and industry feasibility in cosmetics; the need for greater compliance and legal functions at cosmetics companies; where cosmetics and MoCRA could be headed next; and much more.

In our headlines segment, Wayne highlights these major developments:

FDA announces major expansion of internal AI capabilities, including rollout of "Elsa 4.0"

Pharma: FDA seeks input on new efforts to expand drug repurposing

Devices: FDA adds neurosurgical patties to medical device shortage list, warns supply disruptions could impact patient care

Food: FDA launches "Know Your Nutrition" campaign during National Women's Health Week

Cosmetics: PCPC joins coalition filing complaint challenging California's SB 343

In our Resource Links segment, we list key documents in our four core areas. To view these links, subscribe, or find out more information about our podcast, visit FDAWatch.net.

Want to be a sponsor, marketing partner, or guest, or provide feedback on the podcast? Email us at [email protected].

Music by Dvir Silver from Pixabay.